Evidence map›Paper›PMID 41266249›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2026

Efficacy and Safety of Epidermal Radionuclide Therapy with

Paolo Castellucci, Carlotta Baraldi, Luigia Vetrone, Federico Zagni, Claudio Malizia, Alessio Giuseppe Morganti, Lidia Strigari, Emi Dika, Stefano Fanti

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Paolo CastellucciNuclear Medicine IRCCS Azienda Ospedaliero-Universitaria S.Orsola, Bologna, Italy.
Carlotta BaraldiOncologic Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria S.Orsola, Bologna, Italy.
Luigia VetroneNuclear Medicine IRCCS Azienda Ospedaliero-Universitaria S.Orsola, Bologna, Italy; luigia.vetrone@studio.unibo.it.
Federico ZagniDepartment of Medical Physics, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Claudio MaliziaNuclear Medicine IRCCS Azienda Ospedaliero-Universitaria S.Orsola, Bologna, Italy.
Alessio Giuseppe MorgantiRadiation Oncology IRCCS Azienda Ospedaliero-Universitaria S.Orsola, Bologna, Italy; and.
Lidia StrigariDepartment of Medical Physics, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Emi DikaOncologic Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria S.Orsola, Bologna, Italy.
Stefano FantiNuclear Medicine IRCCS Azienda Ospedaliero-Universitaria S.Orsola, Bologna, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonmelanoma skin cancer (NMSC) occurs in photoexposed areas and is frequent in the elderly population. Surgical excision remains the treatment of choice whenever feasible. However, alternative approaches are clinically important for patients who are unsuitable for surgery. This study evaluated the efficacy and safety of

Indexed as

EpidermisRadioisotopesRheniumSafetySkin NeoplasmsAgedAged, 80 and overFemaleHumansMaleMiddle AgedTime FactorsTreatment OutcomeRadioisotopesRhenium188Reepidermal radionuclide therapynonmelanoma skin cancernot sealed sources

Identifiers

PMID41266249
PMCPMC12866359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.